Open Access

CacyBP/SIP promotes tumor progression by regulating apoptosis and arresting the cell cycle in osteosarcoma

  • Authors:
    • Ming Zhao
    • Run‑Zi Zhang
    • Dian‑Wen Qi
    • Hong‑Yi Chen
    • Guo‑Chuan Zhang
  • View Affiliations

  • Published online on: June 5, 2020     https://doi.org/10.3892/etm.2020.8843
  • Pages: 1397-1404
  • Copyright: © Zhao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Osteosarcoma (OS) is the most common primary malignant bone tumor in pediatric and adolescent patients. The calcyclin‑binding protein/Siah‑1‑interacting protein (CacyBP/SIP) performs an essential function in cell proliferation and apoptosis. The present study investigated the effect of CacyBP/SIP in OS cell proliferation and apoptosis. CacyBP/SIP mRNA expression levels were evaluated in four OS cell lines by quantitative PCR. CacyBP/SIP expression was downregulated in Saos‑2 cells using a lentivirus transfection system and the transfection efficiency was analyzed. The effects of CacyBP/SIP downregulation on Saos‑2 cell proliferation and colony‑formation ability were evaluated by MTT and colony‑formation assays. The effect of CacyBP/SIP knockdown on Saos‑2 cell cycle and apoptosis was analyzed by flow cytometry cell sorting. The Cancer Genome Atlas (TCGA) data was analyzed for validation. Human OS cell lines Saos‑2, MG‑63, HOS and U20S expressed CacyBP/SIP mRNA. CacyBP/SIP knockdown significantly inhibited cell proliferation and colony‑formation ability. G1/S phase arrest was induced by CacyBP/SIP downregulation, which also resulted in the downregulation of CDK and cyclins and the upregulation of p21. In addition, CacyBP/SIP downregulation induced Saos‑2 cell apoptosis mediated by Bax and Bcl‑2. High expression of CacyBP/SIP was significantly associated with poor prognosis in TCGA sarcoma database. Thus, CacyBP/SIP performs important functions in the proliferation and apoptosis of human OS cells.

Related Articles

Journal Cover

August-2020
Volume 20 Issue 2

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Zhao, M., Zhang, R., Qi, D., Chen, H., & Zhang, G. (2020). CacyBP/SIP promotes tumor progression by regulating apoptosis and arresting the cell cycle in osteosarcoma. Experimental and Therapeutic Medicine, 20, 1397-1404. https://doi.org/10.3892/etm.2020.8843
MLA
Zhao, M., Zhang, R., Qi, D., Chen, H., Zhang, G."CacyBP/SIP promotes tumor progression by regulating apoptosis and arresting the cell cycle in osteosarcoma". Experimental and Therapeutic Medicine 20.2 (2020): 1397-1404.
Chicago
Zhao, M., Zhang, R., Qi, D., Chen, H., Zhang, G."CacyBP/SIP promotes tumor progression by regulating apoptosis and arresting the cell cycle in osteosarcoma". Experimental and Therapeutic Medicine 20, no. 2 (2020): 1397-1404. https://doi.org/10.3892/etm.2020.8843